
    
      Single center, blinded, randomized, parallel-group, comparative study of Lymphoseek and
      99mTc-SC in the preoperative and intraoperative detection of lymph nodes in subjects with
      known breast cancer. All subjects will receive a single dose of 50 Î¼g Lymphoseek radiolabeled
      with 0.5 millicurie (mCi) Tc 99m or 0.5 mCi of 99mTc-SC. Subjects may also receive up to 1 mL
      of vital blue dye (VBD) as a companion ILM agent. All radio-labeled agents will be
      administered in a single intradermal injection.
    
  